Skip to content

Clinical trials

Expanded access trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: France Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available15
Approved for marketing8
Available6
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Alexion Pharmaceuticals, Inc.2
Bayer2
Impatients N.V. trading as myTomorrows2
Nuvalent Inc.2
Pfizer2
Amgen1
Astellas Pharma Global Development, Inc.1
BioMarin Pharmaceutical1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung3
Breast Neoplasms2
COVID-192
Pancreatic Neoplasms2
Recurrence2
Acute Lung Injury1
Adenocarcinoma1
Bone Diseases1
Carcinoma, Hepatocellular1
Carcinoma, Medullary1

Trials

Showing 76 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.